Biessels, G. ., Janssen, J. ., van den Berg, E. ., Zinman, B. ., Espeland, M. ., Mattheus, M. ., … CAROLINA®, investigators. . (2018). Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus. BMC Neurology, 18(1), 7. https://doi.org/10.1186/s12883-018-1014-7 (Original work published 2018)

Tran, S. ., Retnakaran, R. ., Zinman, B. ., & Kramer, C. . (2018). Efficacy of glucagon-like peptide-1 receptor agonists compared to dipeptidyl peptidase-4 inhibitors for the management of type 2 diabetes: A meta-analysis of randomized clinical trials. Diabetes, Obesity & Metabolism, 20 Suppl 1, 68-76. https://doi.org/10.1111/dom.13137

Mann, J. ., Ørsted, D. ., Brown-Frandsen, K. ., Marso, S. ., Poulter, N. ., Rasmussen, S. ., … and, I. L. S. C. (2017). Liraglutide and Renal Outcomes in Type 2 Diabetes. The New England Journal of Medicine, 377(9), 839-848. https://doi.org/10.1056/NEJMoa1616011 (Original work published 2017)

Marso, S. ., McGuire, D. ., Zinman, B. ., Poulter, N. ., Emerson, S. ., Pieber, T. ., … Study, G. D. (2017). Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes. The New England Journal of Medicine, 377(8), 723-732. https://doi.org/10.1056/NEJMoa1615692 (Original work published 2017)